EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Guillain‐Barré syndrome: a comprehensive review

Roberto Bellanti iD, Simon Rinaldi

European Journal of Neurology · 2024-08 · 31 (8)

DOI: 10.1111/ene.16365 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Neurology, online erschienen am 30.05.2024. Verfasst von Roberto Bellanti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Guillain-Barre Syndrome. Die Arbeit wurde bisher 160-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Guillain‐Barré syndrome (GBS) is a potentially devastating yet treatable disorder. A classically postinfectious, immune‐mediated, monophasic polyradiculoneuropathy, it is the leading global cause of acquired neuromuscular paralysis. In most cases, the immunopathological process driving nerve injury is ill‐defined. Diagnosis of GBS relies on clinical features, supported by laboratory findings and electrophysiology. Although previously divided into primary demyelinating or axonal variants, this dichotomy is increasingly challenged, and is not endorsed by the recent European Academy of Neurology (EAN)/Peripheral Nerve Society (PNS) guidelines. Intravenous immunoglobulin and plasma exchange remain the primary modalities of treatment, regardless of the electrophysiological subtype. Most patients recover, but approximately one‐third require mechanical ventilation, and 5% die. Disease activity and treatment response are currently monitored through interval neurological examination and outcome measures, and the potential role of fluid biomarkers is under ongoing scrutiny. Novel potential therapies for GBS are being explored but none have yet modified clinical practice. This review provides a comprehensive update on the pathological and clinical aspects of GBS for clinicians and scientists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Guillain-Barre SyndromeHumansPlasma ExchangeImmunoglobulins, Intravenous

Stichwörter der Autor:innen

Guillain‐Barré syndromediagnosisimmunopathologyprognosistreatment

Substanzen

Immunoglobulins, Intravenous

Autor:innen und Institutionen

  • Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

ORCID-Profile: Roberto Bellanti

Zitieren

APA

Bellanti, R., & Rinaldi, S. (2024). Guillain‐Barré syndrome: a comprehensive review. European Journal of Neurology, 31(8). https://doi.org/10.1111/ene.16365

Vancouver

Bellanti R, Rinaldi S. Guillain‐Barré syndrome: a comprehensive review. European Journal of Neurology. 2024;31(8). doi:10.1111/ene.16365

BibTeX
@article{Bellanti2024,
  author = {Bellanti, Roberto and Rinaldi, Simon},
  title = {Guillain‐Barré syndrome: a comprehensive review},
  journal = {European Journal of Neurology},
  year = {2024},
  volume = {31},
  number = {8},
  doi = {10.1111/ene.16365}
}
Kostenlos starten →